Innovative Food Holdings (IVFH) director reports 288,890-share purchase

Rhea-AI Filing Summary

Innovative Food Holdings director Mark Schmulen reported a significant insider purchase of the company’s common stock. On January 6, 2026, he bought 288,890 shares of Innovative Food Holdings common stock at $0.30 per share, according to the Form 4. The filing notes this transaction was made under a stock purchase agreement dated December 19, 2025.

Following this purchase, Schmulen directly owns 345,234 shares of Innovative Food Holdings common stock. This filing shows a director increasing his personal stake through a negotiated share purchase rather than through derivative securities or options.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schmulen Mark

(Last) (First) (Middle)

11115 WICKWAY DR

(Street)

HOUSTON TX 77024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INNOVATIVE FOOD HOLDINGS INC [ IVFH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/06/2026		P		288,890(1)	A	$0.3	345,234	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person entered into a stock purchase agreement, dated as of December 19, 2025, to purchase 288,890 shares of the Issuer's common stock from the seller at a price of $0.30 per share.

	/s/ Mark Schmulen	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider involved in the IVFH transaction reported here?

The insider is Mark Schmulen, who is identified in the filing as a director of Innovative Food Holdings Inc.

What did Innovative Food Holdings (IVFH) director Mark Schmulen purchase?

He purchased 288,890 shares of Innovative Food Holdings common stock.

At what price did the IVFH director buy the shares?

Mark Schmulen bought the shares at a price of $0.30 per share, as disclosed in the Form 4.

When did the IVFH insider share purchase take place?

The transaction date reported is January 6, 2026.

How many Innovative Food Holdings shares does Mark Schmulen own after this transaction?

After the reported purchase, he beneficially owns 345,234 common shares directly.

Was the IVFH insider transaction related to derivatives or options?

No. The Form 4 shows activity only in non-derivative common stock, and the derivative securities table is empty.

How were the purchased IVFH shares acquired by the director?

According to the explanation of responses, the shares were acquired through a stock purchase agreement dated December 19, 2025, at $0.30 per share.